Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

The book, Uncancelable: The Incredible Rise of Mac G chronicles the podcaster’s journey from a young boy in Venda with a ...

RFK Jr, diagnosed with spasmodic dysphonia, is in the news for his confirmation hearing as the United States Secretary of ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

AXSM stock is riding on upbeat preliminary 2024 results. The company's depression drug, Auvelity, drives its top line while ...

Alkermes wants to augment its pipeline with M&A or licensing deals in serious mental illnesses and substance abuse. “I think anyone who's developing a drug in these spaces, they are probably better ...

In the port city of Latakia, Syria's new Islamist rulers have discovered a warehouse full of children's toys - at least at ...

Medicare adds 15 drugs, including Ozempic and Wegovy, to its price negotiation list, aiming to save billions. Incoming Trump administration will finalize details, but obesity treatment remains ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before President-elect Trump’s inauguration. The Centers for Medicare and ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.